OWASSO, Okla., June 3, 2017 /PRNewswire/ -- Cure-One (formerly known as MED-C), a non-profit organization dedicated to advancing
The N1 Registry seeks to:
"Foundation Medicine has long provided the highest quality of testing, while spearheading efforts for transparency and data sharing," said Dane J. Dickson, M.D., Chief Executive Officer and Founder of Cure-One. "As the leading clinical genomic sequencing laboratory, we are ecstatic for this collaboration with Foundation Medicine, and ultimately what it means for advancing patient care."
"Our collaboration with Cure-One is consistent with Foundation Medicine's approach to data sharing and data transparency, and reinforces our vision that progress in personalized cancer care can best be accelerated through a collaborative exchange of molecular information," said Troy Cox, Chief Executive Officer for Foundation Medicine. "Our expectation is that data collaboration with Cure-One serves as an important exemplar in the oncology community for the benefits of public-private partnerships in the area of data exchange."
Cure-One is an independent, non-profit organization dedicated to advancing precision medicine by helping patients access leading-edge genetic-level testing and treatment. The company seeks to make critical laboratory data readily accessible to physicians, researchers, insurance and pharmaceutical companies to advance disease technologies and develop treatments to improve the quality of care in patients with cancer and chronic diseases. Cure-One strives to bring these key medical groups together to build a world where it is never too late for a cure.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cure-one-announces-foundation-medicine-participation-in-its-n1-registry-300468241.html
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All